Cargando…
Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans
BACKGROUND: It is well known that development of prostate cancer (PC) can be attributed to somatic mutations of the genome, acquired within proto-oncogenes or tumor-suppressor genes. What is less well understood is how germline variation contributes to disease aggressiveness in PC patients. To map g...
Autores principales: | Winter, Jean M., Curry, Natasha L., Gildea, Derek M., Williams, Kendra A., Lee, Minnkyong, Hu, Ying, Crawford, Nigel P. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996485/ https://www.ncbi.nlm.nih.gov/pubmed/29890952 http://dx.doi.org/10.1186/s12864-018-4827-2 |
Ejemplares similares
-
Prostate cancer susceptibility gene HIST1H1A is a modulator of androgen receptor signaling and epithelial to mesenchymal transition
por: Williams, Kendra A., et al.
Publicado: (2018) -
RRP1B is a Metastasis Modifier That Regulates the Expression of Alternative mRNA Isoforms Through Interactions with SRSF1
por: Lee, Minnkyong, et al.
Publicado: (2013) -
Identification of CCDC115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analyses
por: Su, Chang, et al.
Publicado: (2023) -
Mapping of Melanoma Modifier Loci in RET Transgenic Mice
por: Dragani, Tommaso A., et al.
Publicado: (2000) -
Necdin is a breast cancer metastasis suppressor that regulates the transcription of c-Myc
por: Lee, Minnkyong, et al.
Publicado: (2015)